Clinical Trials Directory

Trials / Completed

CompletedNCT05317611

Intravenous Versus Intraperitoneal Instillation of Ondansetron for Decreasing Incidence of Nausea and Vomiting After Laparoscopic Gynecological Surgeries.

Intravenous Versus Intraperitoneal Instillation of Ondansetron for Decreasing Incidence of Nausea and Vomiting After Laparoscopic Gynecological Surgeries: A Randomized Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Zagazig University · Other Government
Sex
Female
Age
21 Years – 60 Years
Healthy volunteers
Accepted

Summary

Study the effect of intraperitoneal instillation vs intravenous ondansetron on PONV added to intraperitoneal bupivacaine for enhanced recovery and to decrease incidence of PONV after laparoscopic surgeries.

Detailed description

Laparoscopic surgeries have many advantages e.g., decreasing postoperative pain, better cosmetic, rapid recovery, and better recovery but also, it has side effects e.g., pain, postoperative nausea and vomiting. There are many risk factors that cause PONV either patient related factors or anesthesia related factors (opioids, inhalational anesthetics, Nitrous oxide and duration of anesthesia) and surgery related factors (intraabdominal, laparoscopic, postoperative pain). Intraperitoneal instillation of drugs can be used for instillation of LA, opoids, ketamine and antiemetics to provide analgesia and manage side effects of laparoscopic surgery. The mechanism of action of ondansetron is inhibition of presynaptic 5-HT3 receptors that located in the peripheral nervous. Study the effect of intraperitoneal instillation vs intravenous ondansetron on PONV added to intraperitoneal bupivacaine for enhanced recovery and to decrease incidence of PONV after laparoscopic surgeries.

Conditions

Interventions

TypeNameDescription
DRUGIntraperitoneal instillation of ondansetron and bupivacaineThe aim is to detect the effect of intraperitoneal instillation of ondansetron for prevention of postoperative nausea and vomiting
DRUGIntravenous ondansetron and intraperitoneal instillation of bupivacaineThe aim is to detect effect of intravenous ondansetron for prevention of postoperative nausea and vomiting
DRUGIntraperitoneal instillation of bupivacaineThe aim is to detect effect of intraperitoneal instillation of bupivacaine

Timeline

Start date
2022-07-01
Primary completion
2025-01-15
Completion
2025-01-26
First posted
2022-04-08
Last updated
2025-02-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05317611. Inclusion in this directory is not an endorsement.